Defeat Cancer by Detecting it Early
EarlyDiagnostics (EarlyDx) is devoted to providing accurate, affordable, and non-invasive liquid biopsy tests for early cancer detection and precision medicine.
Big Data for Better Diagnosis
We have developed a blood test, CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. In addition, we developed a One-Stop Shop bioinformatics solution, EarlyDx-Cloud, to help many diagnostic companies offer liquid biopsy tests for cancer detection, therapy selection, and treatment monitoring.
how it works
The Technology behind Cancer Detection
Our Experts Are Waiting For You
We bring the right people together to challenge established thinking and drive transformation.
Co-founder Jasmine Zhou to Report EarlyDx’s CancerRadar Technology and Clinical Data in Oral Presentation at AACR Annual Meeting 2021 on April 10, 2021.
EarlyDx Awarded an NIH SBIR Phase I Grant for Assay Development.